Canada markets open in 7 hours 11 minutes

Ovid Therapeutics Inc. (OVID)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.1400-0.0100 (-0.32%)
At close: 04:00PM EDT
3.1400 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 222.77M
Enterprise Value 148.21M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)468.24
Price/Book (mrq)2.85
Enterprise Value/Revenue 312.87
Enterprise Value/EBITDA -0.69

Trading Information

Stock Price History

Beta (5Y Monthly) 0.69
52-Week Change 3-8.99%
S&P500 52-Week Change 328.04%
52 Week High 34.1390
52 Week Low 32.5700
50-Day Moving Average 33.0751
200-Day Moving Average 33.3968

Share Statistics

Avg Vol (3 month) 3201.32k
Avg Vol (10 day) 395.89k
Shares Outstanding 570.94M
Implied Shares Outstanding 670.94M
Float 840.75M
% Held by Insiders 115.87%
% Held by Institutions 162.43%
Shares Short (Apr 30, 2024) 42.82M
Short Ratio (Apr 30, 2024) 419.08
Short % of Float (Apr 30, 2024) 44.84%
Short % of Shares Outstanding (Apr 30, 2024) 43.98%
Shares Short (prior month Mar 28, 2024) 42.8M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-11,768.24%

Management Effectiveness

Return on Assets (ttm)-28.09%
Return on Equity (ttm)-50.87%

Income Statement

Revenue (ttm)473.69k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)124.20%
Gross Profit (ttm)N/A
EBITDA -61.25M
Net Income Avi to Common (ttm)-50.68M
Diluted EPS (ttm)-0.7200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)90.26M
Total Cash Per Share (mrq)1.27
Total Debt (mrq)15.7M
Total Debt/Equity (mrq)20.05%
Current Ratio (mrq)10.47
Book Value Per Share (mrq)1.11

Cash Flow Statement

Operating Cash Flow (ttm)-50.35M
Levered Free Cash Flow (ttm)-29.24M